Print Friendly, PDF & Email

NCT/Study#

NCT04521621 /

V937-013

A Phase 1b/2 Clinical Study Of Intratumoral Administration Of V937 In Combination With Pembrolizumab (MK-3475) In Participants With Advanced/Metastatic Solid Tumors

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: